Darabi R, Arpke RW, Irion S, et al., Human ES - and iPS -
derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice.
However, researchers from the laboratory of Nenad Bursac (Duke University, Durham, NC, USA) have recently described the production and differentiation of induced
myogenic progenitor cells (iMPCs) from hPSCs into the first entirely hPSC -
derived 3D muscle tissues that survive, vascularize, and maintain function following transplantation [5].